Good morning, ProviderNation.
The fine folks at Emory University think they’ve found a new lead in Alzheimer’s research: a previously unidentified “protein pathology” that appears in the early stages of the disease and is “not found in other neurodegenerative diseases such as Parkinson’s disease,” according to a release from the university.
“What makes these tangles distinct is that they sequester proteins involved in RNA splicing, the process by which instructional messages from genes are cut and pasted together. The researchers show that the appearance of these tangles is linked to widespread changes in RNA splicing in Alzheimer’s brains compared to healthy brains.
“The finding could change scientists’ understanding of how the disease develops and progresses, by explaining how genes that have been linked to Alzheimer’s contribute their effects, and could lead to new biomarkers, diagnostic approaches, and therapies.”
In other news, Bloomberg discovers that Medicaid is important to long term care companies (subscription required). What’s fascinating is Bloomberg’s analysis of how much it will cost the sector because of states that have rejected Obamacare’s expanded Medicaid offer: $5.3 billion missed out on by skilled nursing centers, $4.4 billion for home health companies.
Over at the Wall Street Journal, AgeWave guy Ken Dychtwald has some thoughts for couples as they get ready to retire.
And the Regenstrief Institute and Indiana University researchers say that things get better in long term care “when state government and nursing homes collaborate in a performance-based incentive program that promotes local solutions to local problems.”